首页 | 本学科首页   官方微博 | 高级检索  
     

^188Re标记单克隆抗体BAC5及对鼻咽癌细胞的抑制实验研究
引用本文:王国慧 刘长征 等. ^188Re标记单克隆抗体BAC5及对鼻咽癌细胞的抑制实验研究[J]. 现代临床医学生物工程学杂志, 2002, 8(2): 111-112
作者姓名:王国慧 刘长征 等
作者单位:[1]中山大学肿瘤防治中心核医学科 [2]中山大学医学院核医学教研室,广州510060
基金项目:广东省自然科学基金资助项目 (940 4 86)
摘    要:
目的 探讨放射性核素^188Re标记抗鼻咽癌(NPC)单抗BAC5的方法及^188Re-BAC5对鼻咽癌进行免疫导向治疗的可行性。方法 ^188Re-BAC5的制备采用直接标记法,采用MTT法观察^188Re-BAC5对体外单层培养的鼻咽癌细胞(CNE-2)的抑制作用,对照组为^188Re-BSA、^188ReO4^-。结果 ^188Re-BAC5的标记率在80%以上,MTT法结果表明^188Re-BAC5组的抑瘤率比对照组明显提高(P<0.05)。结论 提示^188Re-BAC5有可能在对人鼻咽癌的放免导向治疗中起到良好的作用。

关 键 词:实验研究 鼻咽癌 抗体 单克隆 ^188Re MTT
文章编号:1008-634X(2002)02-0111-02
修稿时间:2002-03-17

Experimental Study of the Labeling Method and Inhibitive Effects on Nasopharyngeal Carcinoma Cells of ~(188)Re-BAC_5
WANG Guo-hui,LIU Chang-zheng,FAN Wei,et al.. Experimental Study of the Labeling Method and Inhibitive Effects on Nasopharyngeal Carcinoma Cells of ~(188)Re-BAC_5[J]. Journal of Modern Clinical Medical Bioengineering, 2002, 8(2): 111-112
Authors:WANG Guo-hui  LIU Chang-zheng  FAN Wei  et al.
Abstract:
Objective To investigate the feasibility of targeted therapy on NPC with 188Re-BAC 5. Methods BAC 5 is a kind of monoclonal antibody to NPC.The 188Re-BAC 5 was prepared by direct labeling way.The MTT method was used to determine the inhibitive effect of the 188Re-BAC 5.The control group were 188Re-BSA and 188ReO 4 -. Results The labeling yield of 188Re-BAC 5 was above 80%.The results of MTT showed that the inhibitive effects of 188Re-BAC 5 group was much stronger than that of the control group (p<0.05). Conclusions 188Re-BAC 5 possibly provides a promising may of targeted therapy on NPC in the near future.
Keywords:Nasopharyngeal carcinoma  Monoclonal antibody  188Re  MTT
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号